Search

Vir Biotechnology Inc

Abrir

SetorSaúde

10.56 -2.22

Visão Geral

Variação de preço das ações

24h

Atual

Mín

10.42

Máximo

10.78

Indicadores-chave

By Trading Economics

Rendimento

80M

-46M

Vendas

239M

239M

EPS

0.47

Margem de lucro

-19.09

Funcionários

367

EBITDA

201M

78M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+96.91% upside

Dividendos

By Acuity

Próximos Ganhos

4 de nov. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

426M

1.9B

Abertura anterior

12.78

Fecho anterior

10.56

Sentimento de Notícias

By Acuity

25%

75%

54 / 339 Ranking em Healthcare

Vir Biotechnology Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

9 de set. de 2026, 20:07 UTC

Vir Biotechnology Inc shares are lower today, breaking a trend of higher daily closes. No specific news was identified to explain the decline.

3 de set. de 2026, 19:46 UTC

Vir Biotechnology Inc shares are lower during Thursday's session, reversing early gains amid significant volatility. No specific news was identified to explain the decline.

2 de set. de 2026, 23:16 UTC

Vir Biotechnology shares are lower in after-market trading, despite strong one-month performance. The stock remains above its 20-day moving average.

1 de set. de 2026, 22:06 UTC

Social Media

Vir Biotechnology Inc. has a market cap of $1.6 billion and cash of $1 billion. Shares are higher in after-market trading following recent strong performance.

28 de ago. de 2026, 20:08 UTC

Vir Biotechnology Inc shares are lower today, continuing a decline since Thursday amid rising U.S. Treasury yields and broader market pressures.

27 de ago. de 2026, 20:08 UTC

Vir Biotechnology Inc shares are higher, reflecting a steady upward trend since Wednesday. Broader market conditions may be contributing to this positive movement.

26 de ago. de 2026, 20:08 UTC

Vir Biotechnology Inc is higher in Wednesday's session, continuing its upward trend since Tuesday's close, despite earlier fluctuations in price.

25 de ago. de 2026, 20:09 UTC

Social Media

Vir Biotechnology is gaining as social media discussions highlight its $1 billion cash position and potential catalysts, despite earlier session pullbacks.

24 de ago. de 2026, 21:01 UTC

Vir Biotechnology Inc. shares are trading higher in after-market hours, continuing a recent upward trend amid a rebound in the bond market and lower Treasury yields.

21 de ago. de 2026, 20:02 UTC

Correlated Moves

Vir Biotechnology Inc. shows upward momentum, reflecting significant gains since Thursday's close, amid positive trends in the healthcare sector and broader biotechnology market.

20 de ago. de 2026, 20:02 UTC

Correlated Moves

Vir Biotechnology Inc. shares are trading lower amid a significant decline in the biotechnology sector, influenced by broader market trends and ETF performance.

19 de ago. de 2026, 23:06 UTC

Correlated Moves

Vir Biotechnology Inc's shares are higher in after-market trading, continuing a positive trend and maintaining a position above their 20-day moving average.

18 de ago. de 2026, 19:56 UTC

Vir Biotechnology Inc shares are higher today, reflecting positive market sentiment, despite a pullback from earlier session gains. The stock remains above its 20-day moving average.

17 de ago. de 2026, 21:02 UTC

Vir Biotechnology Inc is trading higher in after-market hours, maintaining positive momentum after eight consecutive sessions of gains and exceeding its 20-day moving average.

11 de ago. de 2026, 19:36 UTC

Vir Biotechnology Inc. shares are trading roughly flat amid geopolitical tensions and anticipation of U.S. inflation reports that could influence Federal Reserve policy.

10 de ago. de 2026, 23:56 UTC

Vir Biotechnology Inc. shares advanced in after-market trading, reflecting a modest increase from Monday's close, though still below the 20-day moving average.

7 de ago. de 2026, 19:36 UTC

Correlated Moves

Vir Biotechnology shares are higher, supported by broader market gains and a notable increase in the ARK Genomic Revolution ETF.

6 de ago. de 2026, 23:21 UTC

Vir Biotechnology Inc shares are higher in after-market trading, showing positive momentum following Thursday's close. No specific news was identified to explain the movement.

5 de ago. de 2026, 23:41 UTC

News
Social Media

Vir Biotechnology reported second-quarter revenue of $238.9 million, exceeding estimates, contributing to significant gains in after-market trading.

3 de ago. de 2026, 19:46 UTC

Vir Biotechnology Inc's shares are higher today, reflecting broader market trends amid falling oil prices. The stock remains below its 20-day moving average.

30 de jul. de 2026, 19:58 UTC

Vir Biotechnology Inc shares are higher today amid a broader recovery in tech stocks, despite breaking a recent trend of higher daily closes.

29 de jul. de 2026, 19:27 UTC

Shares of Vir Biotechnology Inc. are trading lower today, having declined after an initial uptick and hitting a session low in late morning.

28 de jul. de 2026, 15:46 UTC

Correlated Moves

Shares lower today, pressured by declines in biotech sector.

27 de jul. de 2026, 20:07 UTC

Vir Biotechnology's shares are higher today, continuing gains since Friday. The broader market is influenced by declining oil prices and lower Treasury yields.

25 de jul. de 2026, 00:01 UTC

Vir Biotechnology Inc shares are higher in after-market trading, recovering from earlier lows. The stock is near the lower end of its one-month trading range.

24 de jul. de 2026, 23:31 UTC

Vir Biotechnology Inc shares are higher in after-market trading, reflecting notable gains since Friday's close, despite no specific news driving the price action.

21 de jul. de 2026, 17:16 UTC

Correlated Moves

Vir Biotechnology Inc's shares are higher today, supported by a positive trend in the broader biotech sector. Earlier, shares pulled back but have since recovered.

20 de jul. de 2026, 21:02 UTC

Vir Biotechnology Inc shares fell during after-market hours amid broader market declines following a reported drop in the Leading Economic Index for June.

Comparação entre Pares

Variação de preço

Vir Biotechnology Inc Previsão

Preço-alvo

By TipRanks

96.91% parte superior

Previsão para 12 meses

Média 21.286 USD  96.91%

Máximo 30 USD

Mínimo 15 USD

Com base em 8 analistas de Wall Street que oferecem metas de preço de 12 meses para Vir Biotechnology Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

8 ratings

8

Comprar

0

Manter

0

Vender

Sentimento

By Acuity

54 / 339 Ranking em Saúde

Sentimento de Notícias

Evidência Muito Forte de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Vir Biotechnology Inc

Vir Biotechnology, Inc., an immunology company, develops therapeutic products to treat and prevent serious infectious diseases. Its clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). The company's preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metapneumovirus (MPV), and human papillomavirus (HPV). The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune, LLC; collaboration with WuXi Biologics (Hong Kong) Limited and Glaxo Wellcome UK Ltd.; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A, as well as license agreement with Sanofi for three clinical-stage masked T-cell engagers (TCEs) and exclusive use of the protease-cleavable masking platform for oncology and infectious diseases. It also has a manufacturing agreement with Samsung Biologics Co.,Ltd. The company was incorporated in 2016 and is headquartered in San Francisco, California.
help-icon Live chat